[1] J.
Byam,
J.
Renz,
e J.
M.
Millis,
«Liver transplantation for hepatocellular carcinoma»,
Hepatobiliary Surg.
Nutr.,
vol.
2,
n.
1,
pagg.
22–30,
feb.
2013.
[2] European Association For The Study Of The Liver e European Organisation For Research And Treatment Of Cancer,
«EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma»,
J.
Hepatol.,
vol.
56,
n.
4,
pagg.
908–943,
apr.
2012.
[3] C.
Schraml et al.,
«Imaging of HCC-Current State of the Art»,
Diagn.
Basel Switz.,
vol.
5,
n.
4,
pagg.
513–545,
nov.
2015.
[4] J.-Y.
Choi,
J.-M.
Lee,
e C.
B.
Sirlin,
«CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I.
Development,
growth,
and spread: key pathologic and imaging aspects»,
Radiology,
vol.
272,
n.
3,
pagg.
635–654,
set.
2014.
[5] J.
Bruix e M.
Sherman,
«Management of hepatocellular carcinoma: An update»,
Hepatol.
Baltim.
Md,
vol.
53,
n.
3,
pagg.
1020–1022,
mar.
2011.
[6] F.
Bellissimo,
M.
R.
Pinzone,
B.
Cacopardo,
e G.
Nunnari,
«Diagnostic and therapeutic management of hepatocellular carcinoma»,
World J.
Gastroenterol.,
vol.
21,
n.
42,
pagg.
12003–12021,
nov.
2015.
[7] J.
E.
Shriki et al.,
«CT of Atypical and Uncommon Presentations of Hepatocellular Carcinoma»,
Am.
J.
Roentgenol.,
vol.
205,
n.
4,
pagg.
W411–W423,
set.
2015.
[8] «LI-RADS».
[In linea].
Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS.